Symbols / GCTK Stock $0.73 +0.52% GlucoTrack, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
GCTK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Dr. Paul V. Goode Ph.D.
Exch · Country NCM · United States
Market Cap 1.43M
Enterprise Value -2.51M
Income -19.39M
Sales —
FCF (ttm) -9.44M
Book/sh 3.10
Cash/sh 3.80
Employees —
Insider 10d —
IPO Apr 25, 2013
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B 0.24
P/C —
EV/EBITDA 0.16
EV/Sales —
Quick Ratio 1.55
Current Ratio 1.61
Debt/Eq 121.85
LT Debt/Eq —
EPS (ttm) -31.22
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -146.06%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 1.94M
Shs Float 1.79M
Insider Own 3.03%
Instit Own 8.96%
Short Float 34.69%
Short Ratio 0.22
Short Interest 670.48K
52W High 15.90
vs 52W High -95.39%
52W Low 0.62
vs 52W Low 18.47%
Beta 0.61
Impl. Vol. —
Rel Volume 0.09
Avg Volume 1.45M
Volume 123.66K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.73
Price $0.73
Change 0.52%
About

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.73
Latest analyst target
3. DCF / Fair value
$-87.44
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.73
Low
—
High
—
Mean
—
News
RSS: Latest GCTK news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-03 BALO ANDREW K Director — 4,692 $0.00 $0
2025-10-03 CARTER ERIN CATHERINE Director — 1,418 $0.00 $0
2025-10-03 MALAVE LUIS Director — 1,698 $0.00 $0
2025-03-26 BALO ANDREW K Director — 4,490 — —
2025-03-26 FISCHELL ROBERT E. Director — 2,045 — —
2025-03-26 DANZIG ALLEN E Director — 1,771 — —
2025-03-26 CARTER ERIN CATHERINE Director — 3,257 — —
2025-03-26 BALLANTYNE JOHN Director and Beneficial Owner of more than 10% of a Class of Security — 4,126 — —
2025-03-26 MALAVE LUIS Director — 3,199 — —
2025-03-12 GOODE PAUL Chief Executive Officer — 16,231 $31.20 $24,835
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
16.09
+10.61%
14.55
+104.77%
7.10
+60.29%
4.43
Research And Development
9.81
+3.31%
9.50
+101.93%
4.70
+139.15%
1.97
Selling General And Administration
6.28
+24.35%
5.05
+110.60%
2.40
-2.32%
2.45
Selling And Marketing Expense
—
0.39
+222.13%
0.12
0.00
General And Administrative Expense
6.28
+24.35%
5.05
+121.89%
2.27
-7.29%
2.45
Salaries And Wages
—
0.48
+40.00%
0.34
-44.89%
0.62
Other Gand A
6.28
+24.35%
5.05
+215.70%
1.60
+15.87%
1.38
Other Operating Expenses
—
—
—
0.01
Total Expenses
16.09
+10.61%
14.55
+104.77%
7.10
+60.29%
4.43
Operating Income
-16.09
-10.61%
-14.55
-104.77%
-7.10
-60.29%
-4.43
Total Operating Income As Reported
—
-14.55
-104.77%
-7.10
-60.29%
-4.43
EBITDA
-16.05
-10.59%
-14.51
-104.84%
-7.08
-60.67%
-4.41
Normalized EBITDA
-12.78
-42.72%
-8.96
-26.59%
-7.07
-60.44%
-4.41
Reconciled Depreciation
0.04
+16.67%
0.04
+176.92%
0.01
-43.48%
0.02
EBIT
-16.09
-10.61%
-14.55
-104.97%
-7.10
-60.13%
-4.43
Total Unusual Items
-3.27
+41.20%
-5.56
-55460.00%
-0.01
0.00
Total Unusual Items Excluding Goodwill
-3.27
+41.20%
-5.56
-55460.00%
-0.01
0.00
Special Income Charges
0.00
+100.00%
-4.76
0.00
0.00
Other Special Charges
—
4.76
—
—
Write Off
—
—
—
0.00
Net Income
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Pretax Income
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Net Non Operating Interest Income Expense
-0.06
+90.22%
-0.58
-3529.41%
0.02
+54.55%
0.01
Interest Expense Non Operating
—
0.63
0.00
—
Net Interest Income
-0.06
+90.22%
-0.58
-3529.41%
0.02
+54.55%
0.01
Interest Expense
—
0.63
0.00
—
Interest Income Non Operating
—
0.06
+264.71%
0.02
+54.55%
0.01
Interest Income
—
0.06
+264.71%
0.02
+54.55%
0.01
Other Income Expense
-3.24
+56.60%
-7.47
-74570.00%
-0.01
+28.57%
-0.01
Other Non Operating Income Expenses
0.03
+101.36%
-1.91
—
-0.01
Gain On Sale Of Security
-3.27
-309.40%
-0.80
-7880.00%
-0.01
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Net Income From Continuing Operation Net Minority Interest
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Net Income From Continuing And Discontinued Operation
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Net Income Continuous Operations
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Normalized Income
-16.12
+5.40%
-17.04
-140.45%
-7.09
-59.80%
-4.43
Net Income Common Stockholders
-19.39
+14.20%
-22.60
-184.17%
-7.95
-79.30%
-4.43
Otherunder Preferred Stock Dividend
—
0.00
-100.00%
0.85
0.00
Diluted EPS
—
-4,106.00
-100.21%
-2,050.80
-17.86%
-1,740.00
Basic EPS
—
-4,106.00
-100.21%
-2,050.80
-17.86%
-1,740.00
Basic Average Shares
—
0.01
+59.05%
0.00
+34.16%
0.00
Diluted Average Shares
—
0.01
+59.05%
0.00
+34.16%
0.00
Diluted NI Availto Com Stockholders
-19.39
+14.20%
-22.60
-184.17%
-7.95
-79.30%
-4.43
Depreciation Amortization Depletion Income Statement
—
0.02
+633.33%
0.00
+0.00%
0.00
Depreciation And Amortization In Income Statement
—
0.02
+633.33%
0.00
+0.00%
0.00
Depreciation Income Statement
—
0.02
+633.33%
0.00
+0.00%
0.00
Insurance And Claims
—
0.31
-6.85%
0.34
-26.48%
0.46
Total Other Finance Cost
0.06
-90.22%
0.58
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
7.84
+32.13%
5.93
+20.94%
4.91
+101.19%
2.44
Current Assets
7.67
+32.92%
5.77
+18.49%
4.87
+104.62%
2.38
Cash Cash Equivalents And Short Term Investments
7.38
+31.44%
5.62
+25.04%
4.49
+94.29%
2.31
Cash And Cash Equivalents
7.38
+31.44%
5.62
+25.04%
4.49
+94.29%
2.31
Receivables
—
—
—
—
Accounts Receivable
—
—
—
—
Inventory
—
—
—
—
Raw Materials
—
—
—
—
Work In Process
—
—
—
—
Finished Goods
—
—
—
—
Other Current Assets
0.28
+88.08%
0.15
-59.84%
0.38
+461.19%
0.07
Total Non Current Assets
0.17
+4.27%
0.16
+343.24%
0.04
-37.29%
0.06
Net PPE
0.17
+11.04%
0.15
+470.37%
0.03
-32.50%
0.04
Gross PPE
0.17
+11.04%
0.15
+470.37%
0.03
-32.50%
0.04
Accumulated Depreciation
—
—
—
-0.25
Properties
—
—
—
—
Machinery Furniture Equipment
—
—
—
0.29
Other Properties
0.17
+11.04%
0.15
+470.37%
0.03
-32.50%
0.04
Leases
—
—
—
—
Other Non Current Assets
—
0.01
+0.00%
0.01
-47.37%
0.02
Total Liabilities Net Minority Interest
5.01
-73.54%
18.93
+1008.43%
1.71
+41.39%
1.21
Current Liabilities
4.77
+274.35%
1.27
-15.67%
1.51
+49.26%
1.01
Payables And Accrued Expenses
1.32
+32.76%
0.99
+18.24%
0.84
+24.85%
0.67
Payables
1.32
+32.76%
0.99
+18.24%
0.84
+24.85%
0.67
Accounts Payable
1.32
+32.76%
0.99
+18.24%
0.84
+24.85%
0.67
Current Accrued Expenses
—
—
—
0.33
Pensionand Other Post Retirement Benefit Plans Current
—
—
—
0.02
Current Debt And Capital Lease Obligation
3.21
+10254.84%
0.03
—
—
Current Debt
3.18
+63540.00%
0.01
—
—
Other Current Borrowings
—
0.01
—
—
Current Capital Lease Obligation
0.03
+7.69%
0.03
0.00
0.00
Other Current Liabilities
0.25
-2.38%
0.25
-62.56%
0.67
+97.36%
0.34
Total Non Current Liabilities Net Minority Interest
0.24
-98.66%
17.66
+8908.67%
0.20
+0.51%
0.20
Long Term Debt And Capital Lease Obligation
0.24
+0.00%
0.24
+20.41%
0.20
+0.51%
0.20
Long Term Debt
0.23
+13.79%
0.20
+3.57%
0.20
+0.51%
0.20
Long Term Capital Lease Obligation
0.01
-84.85%
0.03
0.00
0.00
Stockholders Equity
2.83
+121.75%
-13.00
-506.63%
3.20
+159.92%
1.23
Common Stock Equity
2.83
+121.75%
-13.00
-506.63%
3.20
+159.92%
1.23
Capital Stock
0.00
+0.00%
0.00
0.00
-100.00%
0.01
Common Stock
0.00
+0.00%
0.00
0.00
-100.00%
0.01
Share Issued
0.91
+6802.81%
0.01
+278.89%
0.00
+34.80%
0.00
Ordinary Shares Number
0.91
+6802.81%
0.01
+278.89%
0.00
+34.80%
0.00
Additional Paid In Capital
151.08
+26.71%
119.23
+5.53%
112.99
+9.59%
103.09
Retained Earnings
-151.84
-14.64%
-132.45
-20.57%
-109.85
-7.80%
-101.90
Gains Losses Not Affecting Retained Earnings
0.04
+612.50%
-0.01
-150.00%
0.02
-5.88%
0.02
Other Equity Adjustments
0.04
+612.50%
-0.01
-150.00%
0.02
-5.88%
0.02
Total Equity Gross Minority Interest
2.83
+121.75%
-13.00
-506.63%
3.20
+159.92%
1.23
Total Capitalization
3.06
+123.90%
-12.80
-477.16%
3.39
+138.11%
1.43
Working Capital
2.89
-35.59%
4.49
+33.88%
3.36
+145.68%
1.37
Invested Capital
6.24
+148.79%
-12.79
-477.01%
3.39
+138.11%
1.43
Total Debt
3.45
+1190.64%
0.27
+36.22%
0.20
+0.51%
0.20
Capital Lease Obligations
0.03
-44.07%
0.06
0.00
0.00
Net Tangible Assets
2.83
+121.75%
-13.00
-506.63%
3.20
+159.92%
1.23
Tangible Book Value
2.83
+121.75%
-13.00
-506.63%
3.20
+159.92%
1.23
Current Notes Payable
3.18
0.00
—
—
Derivative Product Liabilities
0.00
-99.99%
17.42
0.00
—
Inventories Adjustments Allowances
—
—
—
—
Other Equity Interest
3.54
+1454.39%
0.23
+375.00%
0.05
+1100.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-15.24
-22.02%
-12.49
-90.45%
-6.56
-75.86%
-3.73
Cash Flow From Continuing Operating Activities
-15.24
-22.02%
-12.49
-90.45%
-6.56
-75.86%
-3.73
Net Income From Continuing Operations
-19.39
+14.20%
-22.60
-218.40%
-7.10
-60.02%
-4.43
Depreciation Amortization Depletion
0.04
+16.67%
0.04
+176.92%
0.01
-43.48%
0.02
Depreciation
0.04
+16.67%
0.04
+176.92%
0.01
-43.48%
0.02
Depreciation And Amortization
0.04
+16.67%
0.04
+176.92%
0.01
-43.48%
0.02
Other Non Cash Items
0.40
-95.54%
9.03
+16323.64%
0.06
-6.78%
0.06
Stock Based Compensation
0.21
+21.97%
0.17
-38.43%
0.28
-35.99%
0.44
Operating Gains Losses
3.28
+311.40%
0.80
—
0.00
Gain Loss On Investment Securities
3.27
+309.40%
0.80
—
—
Gain Loss On Sale Of PPE
0.02
0.00
0.00
-100.00%
0.00
Change In Working Capital
0.21
+211.94%
0.07
-64.74%
0.19
+3.26%
0.18
Change In Receivables
—
—
—
0.00
Changes In Account Receivables
—
—
—
0.00
Change In Inventory
—
—
—
0.00
Change In Payables And Accrued Expense
0.33
+23.57%
0.26
+57.49%
0.17
+125.68%
0.07
Change In Payable
0.33
+23.57%
0.26
+57.49%
0.17
+125.68%
0.07
Change In Account Payable
0.33
+23.57%
0.26
+57.49%
0.17
+125.68%
0.07
Change In Other Current Assets
-0.13
-159.11%
0.23
+172.82%
-0.31
-1003.57%
-0.03
Change In Other Current Liabilities
0.02
+104.04%
-0.42
-226.81%
0.33
+140.58%
0.14
Investing Cash Flow
-0.10
+7.69%
-0.10
0.00
-100.00%
0.00
Cash Flow From Continuing Investing Activities
-0.10
+7.69%
-0.10
0.00
-100.00%
0.00
Net PPE Purchase And Sale
-0.10
+7.69%
-0.10
0.00
-100.00%
0.00
Purchase Of PPE
-0.10
+7.69%
-0.10
0.00
+100.00%
-0.00
Sale Of PPE
—
—
0.00
-100.00%
0.00
Capital Expenditure
-0.10
+7.69%
-0.10
—
-0.00
Financing Cash Flow
17.04
+24.01%
13.74
+57.42%
8.73
0.00
Cash Flow From Continuing Financing Activities
17.04
+24.01%
13.74
+57.42%
8.73
0.00
Net Issuance Payments Of Debt
3.00
-32.74%
4.46
0.00
—
Issuance Of Debt
3.00
-32.74%
4.46
0.00
—
Short Term Debt Issuance
3.00
-32.74%
4.46
0.00
—
Net Short Term Debt Issuance
3.00
-32.74%
4.46
0.00
—
Net Common Stock Issuance
14.21
+53.06%
9.28
+6.33%
8.73
0.00
Proceeds From Stock Option Exercised
-0.17
0.00
—
—
Changes In Cash
1.71
+48.56%
1.15
-47.10%
2.17
+158.26%
-3.73
Effect Of Exchange Rate Changes
0.05
+304.17%
-0.02
-2300.00%
-0.00
+98.15%
-0.05
Beginning Cash Position
5.63
+24.99%
4.50
+93.14%
2.33
-61.87%
6.11
End Cash Position
7.38
+31.21%
5.63
+24.99%
4.50
+93.14%
2.33
Free Cash Flow
-15.34
-21.77%
-12.59
-92.04%
-6.56
-75.82%
-3.73
Interest Paid Supplemental Data
—
—
0.00
—
Common Stock Issuance
14.21
+53.06%
9.28
+6.33%
8.73
0.00
Issuance Of Capital Stock
14.21
+53.06%
9.28
+6.33%
8.73
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category